GlassScriptPhysician profile
Tarak J Patel
NPI 1013954221
$11,016.36
in general payments reported to CMS, 2019-2025
43 companies · $2,466 in 2025
The $2,466 reported for 2025 was more than what 93% of Pediatric Pulmonology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,228 · 2020: $486 · 2021: $874 · 2022: $2,743 · 2023: $1,478 · 2024: $1,741 · 2025: $2,466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,268 · Education: $417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,268.29 |
| Education | $417.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,885.83 | 2021-2025 | |
| Harmony Biosciences LLC | $1,346.25 | 2020-2025 | Wakix |
| Regeneron Healthcare Solutions, INC. | $1,161.80 | 2019-2025 | Dupixent |
| Glaxosmithkline, LLC. | $917.44 | 2019-2025 | Nucala |
| Astrazeneca Pharmaceuticals LP | $915.31 | 2019-2025 | Fasenra, Tezspire |
| Jazz Pharmaceuticals INC. | $609.21 | 2019-2025 | |
| Baxter Healthcare | $577.55 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System, Hillrom - Volara System |
| Electromed, INC. | $423.47 | 2019-2025 | Smartvest |
| Amgen INC. | $314.14 | 2021-2025 | Tezspire |
| Pharming Healthcare, INC. | $272.70 | 2023-2025 | Ruconest |
| Avadel Cns Pharmaceuticals, LLC | $269.53 | 2024-2025 | Lumryz |
| Philips North America LLC | $266.37 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Biogen, INC. | $255.71 | 2019-2025 | Spinraza, Spinraza |
| Advanced Respiratory, INC | $185.04 | 2020-2021 | |
| Sobi, INC | $146.73 | 2019-2023 |
Show all 41 companies
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarak Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.